Will there be an FDA approved medication to lower lp(a) by the end of 2027?
One-OffHealth & Medicine1aManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 54.3%
Prévisionnistes
9
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 9 heures
Obsolète4 janv. 26, 01:19 UTC31 déc. 27, 23:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2027?
Manifold MarketsWill there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2028?
Manifold MarketsOrion (a device that promises to project artificial vision into the brains of blind people) approved for sale by the end of 2027?
FutuurRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurRègles
There is currently no FDA-approved treatment for Lp(a).
- This market resolves YES if at least one medication specifically designed to lower Lp(a) receives FDA approval by December 31, 2027.
- The medication must be approved for the indication of lowering Lp(a) levels, not merely as a secondary effect of another approved drug.
- Resolution will be verified through the FDA's official approval announcements or the FDA's drug database at https://www.fda.gov/drugs/novel-drug-approvals-fda.
- Must be a medication.
- Lipoprotein apheresis does not count.
Marchés ouverts
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- 15,6 M €
- Volume 24h
- 18,3 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- 1,6 M €
- Volume 24h
- 5,2 k €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 résultats de plus
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- 916 k €
- Volume 24h
- 1,5 k €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 résultats de plus
- Volume total
- 863,6 k €
- Volume 24h
- 1 k €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Will there be an FDA approved medication to lower lp(a) by the end of 2027? ?
- Manifold Markets cote No à 54% au 8 septembre 2026.
- Quand Will there be an FDA approved medication to lower lp(a) by the end of 2027? sera-t-il résolu ?
- Will there be an FDA approved medication to lower lp(a) by the end of 2027? doit être résolu le 31 décembre 2027.
- Comment Will there be an FDA approved medication to lower lp(a) by the end of 2027? est-il réglé ?
- Manifold Markets règle ce marché comme suit : There is currently no FDA-approved treatment for Lp(a).